Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Liposome Stories

2013-05-22 08:28:16

Patents Extend ThermoDox® IP to 2026 in Largest Markets for Hepatocellular Carcinoma LAWRENCEVILLE, N.J., May 22, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that its proprietary patent application, "Method of Storing Nanoparticle Formulations," has now been granted in the four largest markets for liver cancer globally: China, Japan, South Korea and most recently Taiwan. Celsion holds an exclusive license agreement with Duke University for its...

2013-05-16 14:58:11

A new study from the University of Cincinnati (UC) College of Medicine has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA). The novel delivery method involved trapping plasmin into bubble-like liposomes, delivering them to the clot intravenously and bursting it via ultrasound. That method is necessary, says UC associate professor of...

2013-04-23 08:25:07

Ground-breaking technology enables formulation and preparation of unique drug delivery systems WOBURN, Mass., April 23, 2013 /PRNewswire/ -- Covaris, Inc. today announced the introduction of the FS220-M High Performance Formulation Processing System. The FS220-M system extends the company's groundbreaking Adaptive Focused Acoustics (AFA) technology platform and has the ability to process sample volumes ranging from microliters to liters with a true continuous flow...

Those Special Fat Additives In Your Beauty Cream Do Not Work
2013-02-20 11:32:16

April Flowers for redOrbit.com - Your Universe Online Many beauty products that make their way onto store shelves come added with liposomes. The beauty industry states that these liposomes, or small fat capsules, are capable of transporting active ingredients deep into the skin where they release the active ingredients so that they can alter the skin's structure by rejuvenating and smoothing the skin. However, a new study from the University of Southern Denmark, published in the Journal...

2013-02-13 08:26:56

WOBURN, Mass., Feb. 13, 2013 /PRNewswire/ -- Covaris, Inc., the leader in focused acoustic technologies for the life sciences, is pleased to announce the establishment of a marketing alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan. This alliance integrates the Covaris Adaptive Focused Acoustics (AFA) and the HORIBA particle sizing technologies into the world's first fully automated formulation preparation...

2013-02-05 20:21:09

LAWRENCEVILLE, N.J., Feb. 5, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that Zheijang HISUN Pharmaceutical Company (HISUN) does not plan to pursue the exclusive option to license ThermoDox® for the Greater China market. Accordingly, the parties will not enter into the exclusive license agreement, and Celsion will not receive nor will it require any future payment for the option or license, as contemplated in the Exclusive Option Agreement announced on January...

2013-01-15 07:17:42

CHICAGO, Jan. 15, 2013 /PRNewswire-iReach/ -- In our fast paced society, it's no surprise that millions of Americans are battling with too much stress, too much body fat, and too little sleep. Most people suffer all three! (Photo: http://photos.prnewswire.com/prnh/20130115/CG42320) Many seek immediate relief from OTC or prescription medication. But they run the inherent risk of becoming addicted to the pills or experiencing serious side effects. On the other hand, the millions of people...

2012-11-27 08:29:17

Research presented at 2012 SABCS examines cardiac safety profile of MM-302, a new HER2-targeted Liposomal Doxorubicin Agent. CAMBRIDGE, Mass., Nov. 27, 2012 /PRNewswire-USNewswire/ -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer...

2012-11-12 04:23:36

STOCKHOLM, Sweden, November 12, 2012 /PRNewswire/ -- Pharmalink AB, a Swedish specialty pharma company, today announces it has entered into a service contract with GP Pharm for the manufacturing of Pharmalink's Busulipo(TM), which is under development to provide a best-in-class conditioning agent for use prior to hematopoietic stem cell transplantation (HSCT), often known as bone marrow transplantation. GP Pharm is a Spanish biopharmaceutical company that focuses on injectable...

2012-07-11 02:23:19

LAS VEGAS, July 11, 2012 /PRNewswire/ -- Elite athletes from around the world will compete for the title of the fittest man and woman on Earth at the Reebok CrossFit Games in Los Angeles, California, July 13-15. One major contender, Cheryl Brost, will be powered by two of the most effective nutritional supplements on Earth - Altrient(TM) C and Altrient(TM) ME(TM). (Photo: http://photos.prnewswire.com/prnh/20120711/LA38364) (Logo: http://photos.prnewswire.com/prnh/20111206/LA16628LOGO)...